Bicara Therapeutics BCAX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $323.46M-30.0% | $96.69M-80.3% | $171.67M-67.0% | $436.61M+114% | $462.07M— | ||
| —— | —— | —— | —— | —— | ||
| $544.92M— | $422.05M— | $297.37M— | $444.39M— | —— | ||
| $346K— | $330K— | $135K— | $117K— | —— | ||
| $553.6M— | $430.99M— | $424.69M— | $453.59M— | —— | ||
| $39.34M— | $28.95M— | $21.03M— | $17.23M— | —— | ||
| $39.64M— | $29.54M— | $21.91M— | $18.39M— | —— | ||
| 500M— | 500M— | 500M— | 500M— | —— | ||
| -$415.18M— | -$358.97M— | -$321.58M— | -$285.25M— | —— | ||
| $513.96M+12.0% | $401.45M-18.4% | $402.78M-21.0% | $435.2M+349% | $458.96M+387% | ||
| $553.6M— | $430.99M— | $424.69M— | $453.59M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Bicara Therapeutics's total assets?
- Bicara Therapeutics (BCAX) holds $553.6M in total assets, up 15.8% year over year.
- How much debt does Bicara Therapeutics have?
- Bicara Therapeutics carries $1.4M in total debt against $514.0M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Bicara Therapeutics have?
- Bicara Therapeutics holds $323.5M in cash and equivalents.
- Can Bicara Therapeutics cover its short-term obligations?
- Its current ratio is 13.85 — current assets exceed current liabilities.
- Where does Bicara Therapeutics's balance sheet data come from?
- Every line is extracted from Bicara Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.